• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核受体的变构小分子调节剂。

Allosteric small molecule modulators of nuclear receptors.

机构信息

Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612AZ, Eindhoven, the Netherlands.

Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612AZ, Eindhoven, the Netherlands.

出版信息

Mol Cell Endocrinol. 2019 Apr 5;485:20-34. doi: 10.1016/j.mce.2019.01.022. Epub 2019 Jan 28.

DOI:10.1016/j.mce.2019.01.022
PMID:30703487
Abstract

Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms. Allosteric modulation of NRs via synthetic small molecules has recently emerged as an interesting entry to address the need for small molecules targeting NRs in pathology, via novel modes of action and with beneficial profiles. In this review the general concept of allosteric modulation in drug discovery is first discussed, serving as a background and inspiration for NRs. Subsequently, the review focuses on examples of small molecules that allosterically modulate NRs, with a strong focus on structural information and the ligand binding domain. Recently discovered nanomolar potent allosteric site NR modulators are catapulting allosteric targeting of NRs to the center of attention. The obtained insights serve as a basis for recommendations for the next steps to take in allosteric small molecular targeting of NRs.

摘要

核受体(NRs)是多结构域蛋白,其天然调节通过经典的、正位的配体结合口袋中的配体以及通过域内和域间变构机制发生。通过合成小分子对 NRs 的变构调节最近作为一种有趣的方法出现,通过新的作用模式和有益的特征来满足针对病理学中 NRs 的小分子的需求。在这篇综述中,首先讨论了药物发现中变构调节的一般概念,作为 NRs 的背景和灵感。随后,综述重点介绍了变构调节 NRs 的小分子的例子,重点关注结构信息和配体结合域。最近发现的具有纳米摩尔效力的强效变构 NR 调节剂正在将 NRs 的变构靶向推向关注的中心。获得的见解为变构小分子靶向 NR 的下一步提供了依据。

相似文献

1
Allosteric small molecule modulators of nuclear receptors.核受体的变构小分子调节剂。
Mol Cell Endocrinol. 2019 Apr 5;485:20-34. doi: 10.1016/j.mce.2019.01.022. Epub 2019 Jan 28.
2
Targeting Nuclear Receptors with PROTAC degraders.靶向核受体的 PROTAC 降解剂。
Mol Cell Endocrinol. 2019 Aug 1;493:110452. doi: 10.1016/j.mce.2019.110452. Epub 2019 May 21.
3
Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt.鉴定孤儿核受体 RORγt 独特别构结合位点的分子决定因素。
J Biol Chem. 2020 Jul 3;295(27):9183-9191. doi: 10.1074/jbc.RA120.013581. Epub 2020 May 20.
4
Non-canonical modulators of nuclear receptors.核受体的非经典调节剂。
Bioorg Med Chem Lett. 2016 Sep 1;26(17):4157-64. doi: 10.1016/j.bmcl.2016.07.067. Epub 2016 Jul 29.
5
Allosteric targeting of receptor tyrosine kinases.变构靶向受体酪氨酸激酶。
Nat Biotechnol. 2014 Nov;32(11):1113-20. doi: 10.1038/nbt.3028.
6
Allosteric Binding Sites On Nuclear Receptors: Focus On Drug Efficacy and Selectivity.核受体的变构结合位点:关注药物的疗效和选择性。
Int J Mol Sci. 2020 Jan 14;21(2):534. doi: 10.3390/ijms21020534.
7
Novel Allosteric Modulators of G Protein-coupled Receptors.G蛋白偶联受体的新型变构调节剂
J Biol Chem. 2015 Aug 7;290(32):19478-88. doi: 10.1074/jbc.R115.662759. Epub 2015 Jun 22.
8
Small-Molecule Positive Allosteric Modulators of the -Adrenoceptor Isolated from DNA-Encoded Libraries.从 DNA 编码文库中分离出的 -肾上腺素受体的小分子正变构调节剂。
Mol Pharmacol. 2018 Aug;94(2):850-861. doi: 10.1124/mol.118.111948. Epub 2018 May 16.
9
A conserved surface on the ligand binding domain of nuclear receptors for allosteric control.核受体配体结合域上的变构调控的保守表面。
Mol Cell Endocrinol. 2012 Jan 30;348(2):394-402. doi: 10.1016/j.mce.2011.08.012. Epub 2011 Aug 22.
10
Allosteric Modulators of the Class A G Protein Coupled Receptors.A类G蛋白偶联受体的变构调节剂
Adv Exp Med Biol. 2016;917:185-207. doi: 10.1007/978-3-319-32805-8_9.

引用本文的文献

1
Orphan nuclear receptor transcription factors as drug targets.孤儿核受体转录因子作为药物靶点。
Transcription. 2025 Apr-Jun;16(2-3):224-260. doi: 10.1080/21541264.2025.2521766. Epub 2025 Jul 11.
2
Exploiting allosteric modulation: a new frontier for precision medicine.利用变构调节:精准医学的新前沿。
Mol Biol Rep. 2025 Jun 4;52(1):549. doi: 10.1007/s11033-025-10650-9.
3
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets.健康与疾病中的胆汁酸代谢及信号传导:分子机制与治疗靶点
Signal Transduct Target Ther. 2024 Apr 26;9(1):97. doi: 10.1038/s41392-024-01811-6.
4
Mechanism of antagonist ligand binding to REV-ERBα.拮抗剂配体与 REV-ERBα 结合的机制。
Sci Rep. 2024 Apr 10;14(1):8401. doi: 10.1038/s41598-024-58945-4.
5
Lithocholic acid derivatives as potent modulators of the nuclear receptor RORγt.石胆酸衍生物作为核受体RORγt的有效调节剂
RSC Adv. 2024 Jan 18;14(5):2918-2928. doi: 10.1039/d3ra08086b. eCollection 2024 Jan 17.
6
Enhanced mapping of small-molecule binding sites in cells.增强细胞中小分子结合位点的绘图。
Nat Chem Biol. 2024 Jul;20(7):823-834. doi: 10.1038/s41589-023-01514-z. Epub 2024 Jan 2.
7
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.鉴定破坏雄激素受体共激活蛋白-蛋白相互作用从而改变反式激活的变构调节剂-用于转移性去势抵抗性前列腺癌的药物先导物。
SLAS Discov. 2023 Oct;28(7):325-343. doi: 10.1016/j.slasd.2023.08.001. Epub 2023 Aug 6.
8
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation.靶向替代维生素 E 代谢物结合位点可实现非典型 PPARγ 调节。
J Am Chem Soc. 2023 Jul 12;145(27):14802-14810. doi: 10.1021/jacs.3c03417. Epub 2023 Jun 29.
9
Blockage of PPARγ T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions.阻断 PPARγ T166 磷酸化增强米色脂肪细胞的诱导能力并改善代谢功能障碍。
Cell Death Differ. 2023 Mar;30(3):766-778. doi: 10.1038/s41418-022-01077-x. Epub 2022 Nov 3.
10
A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer.一种新型的化学表型方法鉴定了与结直肠癌和胰腺癌发展有关的唾液酸、维生素 D3 和农药的混合物。
Ecotoxicol Environ Saf. 2022 Mar 15;233:113330. doi: 10.1016/j.ecoenv.2022.113330. Epub 2022 Feb 19.